Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone Deacetylase Inhibitors and Papillary Thyroid Cancer

14 Dec 2020

Abstract excerpt

BACKGROUND/AIM: Papillary Thyroid Cancer (PTC) is the most common type of endocrine malignancy. Although PTC has an excellent prognosis, the recurrent or metastatic disease could affect patients' survival. Recent studies show that Histone Deacetylase Inhibitors (HDACIs) might be promising anticancer agents against PTC. The aim of this review is to evaluate the role of HDACIs as an additional modality in PTC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Histone Deacetylase Inhibitors Research
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33308111
DOI: 10.2174/1381612826666201211112234

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone Deacetylase Inhibitors and Papillary Thyroid CancerPMID 33308111Read ↗

Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World TherapySemantic proximity Read ↗

Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell DeathSemantic proximity Read ↗

Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomasSemantic proximity Read ↗

Epigenetics Modifications and Therapeutic Prospects in Human Thyroid CancerSemantic proximity Read ↗

Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell LineSemantic proximity Read ↗

Effect of Valproic Acid on miRNAs Affecting Histone Deacetylase in a Model of Anaplastic Thyroid CancerSemantic proximity Read ↗

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.Semantic proximity Read ↗

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.Semantic proximity Read ↗

Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaSemantic proximity Read ↗

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid CancerSemantic proximity Read ↗

Estimation of Autophagy Activity By Evaluating Possible MicroRNA Biomarkers and FOXO1 mRNA Level in Papillary Thyroid CarcinomaSemantic proximity Read ↗

Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling PathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.